Literature DB >> 18689868

Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Dwight Dickinson1, Philip D Harvey.   

Abstract

The schizophrenia research community, including government, industry, and academia, has made development of procognitive treatment strategies a priority. Much current research is directed at dividing broad impairments in cognition into more delineated components that might correspond to relatively specific neural systems and serve as targets for intervention. Sometimes overlooked in this ambitious agenda is the substantial neuropsychological literature that signals a more broadly generalized dysfunction in higher order cognitive functions in this illness. In this article, we argue that a generalized cognitive deficit is at the core of the disorder, is not a methodological artifact, and deserves more focused consideration from cognitive specialists in the field. Further, we weigh evidence that this broad deficit may have systemic biological underpinnings. At the level of the central nervous system, examples of findings that might help to account for broad cognitive impairment include gray and white matter irregularities, poor signal integration by neurons and neural networks, and abnormalities in glutamate and gamma-aminobutyric acid neurotransmission. Other, more speculative hypotheses focus on even broader somatic systems, including energy metabolism and inflammatory processes. Treatment implications of systemic conceptualizations of schizophrenia are also considered.

Entities:  

Mesh:

Year:  2008        PMID: 18689868      PMCID: PMC2659304          DOI: 10.1093/schbul/sbn097

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  163 in total

1.  Factor structure of the Wechsler Adult Intelligence Scale-III in schizophrenia.

Authors:  Dwight Dickinson; Virginia N Iannone; James M Gold
Journal:  Assessment       Date:  2002-06

2.  A six-factor model of cognition in schizophrenia and related psychotic disorders: relationships with clinical symptoms and functional capacity.

Authors:  Julie Akiko Gladsjo; Lou Ann McAdams; Barton W Palmer; David J Moore; Dilip V Jeste; Robert K Heaton
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

3.  Olfactory functioning in schizophrenia: relationship to clinical, neuropsychological, and volumetric MRI measures.

Authors:  Paul J Moberg; Steven E Arnold; Richard L Doty; Raquel E Gur; Catherine C Balderston; David R Roalf; Ruben C Gur; Christian G Kohler; Stephen J Kanes; Steven J Siegel; Bruce I Turetsky
Journal:  J Clin Exp Neuropsychol       Date:  2006-11       Impact factor: 2.475

4.  Generalized cognitive deficits in schizophrenia: a study of first-episode patients.

Authors:  S Mohamed; J S Paulsen; D O'Leary; S Arndt; N Andreasen
Journal:  Arch Gen Psychiatry       Date:  1999-08

5.  Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia.

Authors:  D C Javitt; E Liederman; A Cienfuegos; A M Shelley
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

Review 6.  Identification of separable cognitive factors in schizophrenia.

Authors:  Keith H Nuechterlein; Deanna M Barch; James M Gold; Terry E Goldberg; Michael F Green; Robert K Heaton
Journal:  Schizophr Res       Date:  2004-12-15       Impact factor: 4.939

Review 7.  The neuropoietic cytokine family in development, plasticity, disease and injury.

Authors:  Sylvian Bauer; Bradley J Kerr; Paul H Patterson
Journal:  Nat Rev Neurosci       Date:  2007-03       Impact factor: 34.870

8.  Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.

Authors:  Xiang Yang Zhang; Dong Feng Zhou; Pei Yan Zhang; Gui Ying Wu; Lian Yuan Cao; Yu Cun Shen
Journal:  Schizophr Res       Date:  2002-10-01       Impact factor: 4.939

9.  Insulin resistance and executive dysfunction in older persons.

Authors:  Angela M Abbatecola; Giuseppe Paolisso; Marco Lamponi; Stefania Bandinelli; Fulvio Lauretani; Lenore Launer; Luigi Ferrucci
Journal:  J Am Geriatr Soc       Date:  2004-10       Impact factor: 5.562

Review 10.  White matter changes in schizophrenia: evidence for myelin-related dysfunction.

Authors:  Kenneth L Davis; Daniel G Stewart; Joseph I Friedman; Monte Buchsbaum; Philip D Harvey; Patrick R Hof; Joseph Buxbaum; Vahram Haroutunian
Journal:  Arch Gen Psychiatry       Date:  2003-05
View more
  45 in total

Review 1.  Functional impairment in people with schizophrenia: focus on employability and eligibility for disability compensation.

Authors:  Philip D Harvey; Robert K Heaton; William T Carpenter; Michael F Green; James M Gold; Michael Schoenbaum
Journal:  Schizophr Res       Date:  2012-04-13       Impact factor: 4.939

2.  Severity of hypertension predicts the generalized neurocognitive deficit in schizophrenia.

Authors:  Lindsay F Morra; Gregory P Strauss
Journal:  Schizophr Res       Date:  2016-07-07       Impact factor: 4.939

3.  Schizophrenia as a systemic disease.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2009-02-04       Impact factor: 9.306

4.  Fronto-parietal and cingulo-opercular network integrity and cognition in health and schizophrenia.

Authors:  Julia M Sheffield; Grega Repovs; Michael P Harms; Cameron S Carter; James M Gold; Angus W MacDonald; J Daniel Ragland; Steven M Silverstein; Douglass Godwin; Deanna M Barch
Journal:  Neuropsychologia       Date:  2015-05-13       Impact factor: 3.139

5.  Has the generalized deficit become the generalized criticism?

Authors:  Michael F Green; William P Horan; Catherine A Sugar
Journal:  Schizophr Bull       Date:  2012-12-12       Impact factor: 9.306

6.  Relationship between changes in metabolic syndrome constituent components over 12 months of treatment and cognitive performance in first-episode schizophrenia.

Authors:  H K Luckhoff; S Kilian; M R Olivier; L Phahladira; F Scheffler; S du Plessis; B Chiliza; L Asmal; R Emsley
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

Review 7.  Psychopharmacological treatment of neurocognitive deficits in people with schizophrenia: a review of old and new targets.

Authors:  Anthony O Ahmed; Ishrat A Bhat
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

8.  Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).

Authors:  A McCleery; M F Green; G S Hellemann; L E Baade; J M Gold; R S E Keefe; R S Kern; R I Mesholam-Gately; L J Seidman; K L Subotnik; J Ventura; K H Nuechterlein
Journal:  Psychol Med       Date:  2015-04-28       Impact factor: 7.723

9.  Factor structure of neurocognition and functional capacity in schizophrenia: a multidimensional examination of temporal stability.

Authors:  Philip D Harvey; Tenko Raykov; Elizabeth W Twamley; Lea Vella; Robert K Heaton; Thomas L Patterson
Journal:  J Int Neuropsychol Soc       Date:  2013-02-21       Impact factor: 2.892

10.  Does abnormal sleep impair memory consolidation in schizophrenia?

Authors:  Dara S Manoach; Robert Stickgold
Journal:  Front Hum Neurosci       Date:  2009-09-01       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.